Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-03

Clinical Trial Update: Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania

View source ↗

Summary

This ClinicalTrials.gov update reports on the effectiveness of Pfizer's ABRYSVO maternal RSV vaccine in preventing RSV in infants in Western Pennsylvania; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Viruses | Status: ACTIVE_NOT_RECRUITING